RecruitingNot applicableNCT06237790
A Comparative Analysis of Speech Perception Between Cochlear Implant Patients and DFNB9 Patients Receiving Gene Therapy
Studying Rare deafness
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eye & ENT Hospital of Fudan University
- Principal Investigator
- Yilai Shu, M.D. & Ph.D.Eye & ENT Hospital of Fudan University
- Enrollment
- 180 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2024 – 2025
Study locations (6)
- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
- The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
- Eye & ENT Hospital of Fudan University, Shanghai, Shanghai Municipality, China
- West China Hospital, Sichuan University, Chengdu, Sichuan, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06237790 on ClinicalTrials.gov